Literature DB >> 27012802

Avoiding Complications in Gigantomastia.

Russell E Kling1, William D Tobler1, Jeffrey A Gusenoff1, J Peter Rubin2.   

Abstract

Gigantomastia is a disabling condition for patients and presents unique challenges to plastic surgeons. Presentation can occur throughout different phases of life, and treatment often begins with nonoperative measures; however, the most effective way to relieve symptoms is surgical breast reduction. Because of the large amount of tissue removed, surgeons can encounter different intraoperative and postoperative complications. By understanding this disease process and these complications, surgeons can attempt to minimize their occurrences. The authors present an overview of the cause, preoperative evaluation, techniques, and outcomes. Additionally, they present outcomes data from their center on 40 patients.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complications; Gigantomastia; Surgical breast reduction

Mesh:

Year:  2016        PMID: 27012802     DOI: 10.1016/j.cps.2015.12.006

Source DB:  PubMed          Journal:  Clin Plast Surg        ISSN: 0094-1298            Impact factor:   2.017


  3 in total

1.  Risk Factors for Postoperative Complications Following Aesthetic Breast Surgery: A Retrospective Cohort Study of 4973 Patients in China.

Authors:  Lingya Zhang; Jinlong Zheng; Jingpeng Mu; Yunqian Gao; Gehong Li
Journal:  Aesthetic Plast Surg       Date:  2022-08-03       Impact factor: 2.708

2.  Idiopathic gigantomastia in a patient on polypharmacy.

Authors:  Ngoc-Nhu Jennifer Nguyen; Lilia Maria Sanchez; Mariam Yassa; Julie David; Mona El Khoury
Journal:  BJR Case Rep       Date:  2021-06-09

3.  Double-Unit Superomedio-Central (DUS) Pedicle Inverted-T Reduction Mammaplasty in Gigantomastia: A 7-year Single-Center Retrospective Study.

Authors:  A Wolter; S Fertsch; B Munder; P Stambera; T Schulz; M Hagouan; D Janku; K Staemmler; L Grueter; N Abu-Abdallah; K Becker; B Aufmesser; J Kornetka; C Andree
Journal:  Aesthetic Plast Surg       Date:  2021-06-18       Impact factor: 2.326

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.